Molecular Imaging Study of Harmine/DMT: a Basic Research Approach

Clinical trial NCT06252506 · COMPLETED

Trial details

NCT number: NCT06252506
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine

Start date: 2024-01-22
Primary completion: 2025-02-17
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.